Results 71 to 80 of about 1,812,940 (257)
Comparison of sublingual and vaginal misoprostol for second-trimester pregnancy terminations.
Journal of Family and Reproductive Health, 2014 Objective: Comparing sublingual and vaginal misoprostol in second trimester pregnancy termination. Materials and methods: In this study 268 women at 12-24 weeks of gestation candidate for pregnancy termination were enrolled.
Forozan Milani +2 more
doaj
Taiwanese Journal of Obstetrics & Gynecology, 2017 Objective: To evaluate the effects of sequential vaginal and sublingual misoprostol after a vaginal loading dose for second-trimester abortion. Materials and methods: From January 2006 to December 2011, 173 women received an 800-μg vaginal loading dose ...
Ming-Chao Huang +4 more
doaj +1 more source
Route of Allergen Immunotherapy: A Global Look Into Physicians' Motivations
Allergy, EarlyView.Little is known about the factors driving AIT prescription in clinical practice, including the level of personalization from patient to patient. Patient‐centred factors theoretically would favour SLIT prescription. Doctors’ knowledge, training, and country influence the final decision on the route.
Carmen Vidal +42 more
wiley +1 more source
The possible use of sublingual immunotherapy in atopic dermatitis
, 2018 Understanding of atopic dermatitis and the clinical study of allergen immunotherapy. Evaluating the efficacy of sublingual immunotherapy in the aspects of clinical, immunological, barrier changes.általános orvosangolegységes ...
Kim, Hyunjoon
core
FAST RELEASE BIOADHESIVE MICROSPHERES FOR THE SUBLINGUAL ADMINISTRATION OF PROXIMATE PRINCIPLES
, 2002 Bioadhesive microspheres containing proximate principles dispersed in a polymeric matrix are suitable for the sublingual administration of the ...
F. Roversi, F. Cilurzo
core +2 more sources
Allergy, EarlyView.This is the first randomised placebo‐controlled trial of intralymphatic immunotherapy using a microcrystalline tyrosine‐adjuvanted grass pollen allergoid. Three ultrasound‐guided ILIT injections were well tolerated and reduced combined symptom‐medication scores compared with placebo. The findings support further optimisation and clinical development of
Lara Šošić +13 more
wiley +1 more source
Development of a sublingual allergy vaccine for grass pollinosis
, 2010 Franco Frati1,2, Silvia Scurati1, Paola Puccinelli1, Marie David3, Cecile Hilaire4, Maurizio Capecce4, Francesco Marcucci2, Cristoforo Incorvaia51Medical and Scientific Department, Stallergenes, Milan, Italy; 2University Department of Medical and ...
Silvia Scurati +3 more
core
Allergy, EarlyView.ABSTRACT Allergen immunotherapy (AIT) has been acknowledged as the only disease‐modifying treatment for respiratory diseases since its introduction in 1911. Although the efficacy and safety have convincingly been established in numerous randomized clinical trials (RCTs), the AIT study results may vary substantially.
Roy Gerth van Wijk +10 more
wiley +1 more source
The pharmacokinetics of clotiazepam after oral and sublingual administration to volunteers
, 1989 The single dose pharmacokinetics of 5 mg clotiazepam drops, oral tablets, and sublingual tablets were studied in a cross-over study in 6 healthy volunteers (median age 28 yr). The formulations had similar systemic availability.
M. Broggini +5 more
core +1 more source
Pre‐Seasonal Treatment With Recombinant Carrier‐Based Birch Vaccine Improves Birch Pollen Allergy
Allergy, EarlyView.We conducted a two stage SCIT trial with GNR‐127 containing a recombinant fusion protein consisting of Bet v 1 and Mal d 1‐derived peptides fused to PreS from HBV. Stage 1 identified two safe maximum tolerated doses (40 μg and 80 μg). In the following Stage 2, five preseasonal injections were well tolerated, induced dose‐dependent allergen‐specific IgG,
Musa R. Khaitov +43 more
wiley +1 more source